Jan 04, 2018 23:12 pm UTC| Business
NEW YORK, Jan. 04, 2018 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Central District of California on...
Administration Demonstrates Sound Planning Strategy for Future Domestic Oil and Gas Development
Jan 04, 2018 23:12 pm UTC| Business
Houston, TX (US), Jan. 04, 2018 -- Nikki Martin, President of the International Association of Geophysical Contractors (IAGC), today issued the following statement regarding the Interior Department’s 2019-2024 OCS Oil...
Ablexis Announces Licensing of the AlivaMab Mouse to NGM Biopharmaceuticals
Jan 04, 2018 23:12 pm UTC| Business
BURLINGAME, Calif., Jan. 04, 2018 -- Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced a license agreement with NGM...
Novan Announces Proposed Public Offering of Common Stock and Warrants
Jan 04, 2018 23:12 pm UTC| Business
MORRISVILLE, N.C., Jan. 04, 2018 -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock and...
SPS Commerce to Present at the 20th Annual Needham Growth Conference
Jan 04, 2018 23:12 pm UTC| Business
MINNEAPOLIS, Jan. 04, 2018 -- SPS Commerce, Inc. (NASDAQ:SPSC), a leader in retail cloud services, today announced that management will present at the 20th Annual Needham Growth Conference in New York, NY on Thursday,...
Jan 04, 2018 23:12 pm UTC| Business
FREMONT, Calif. , Jan. 04, 2018 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced financial results for its second quarter of fiscal 2018 ended...
REGENXBIO Provides Year-End 2017 Corporate Update
Jan 04, 2018 23:12 pm UTC| Business
- Initiated third cohort dosing of RGX-314 Phase I clinical trial for wet AMD - - Initiated second cohort dosing of RGX-501 Phase I/II clinical trial for HoFH - - Anticipate completing dosing and presenting topline...